Stay updated with breaking news from Aruho co . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Journey Medical (DERM) enters into a second licensing agreement with Maruho to develop and commercialize Qbrexza to treat hyperhidrosis in certain Asian countries. The stock surges 18.4%. ....